NASH has replaced hepatitis C as the most important nonalcoholic liver disease. Biotech and pharma are racing to tap into this enormous market.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Perry, R. J., Samuel, V. T., Petersen, K. F. & Shulman, G. I. Nature 510, 84–91 (2014).
Sanyal, A. J. et al. N. Engl. J. Med. 362, 1675–1685 (2010).
Huang, M. A. et al. Am. J. Gastroenterol. 100, 1072–1081 (2005).
Promrat, K. et al. Hepatology 51, 121–129 (2010).
Parks, D. J. et al. Science 284, 1365–1368 (1999).
Holt, J. A. et al. Genes Dev. 17, 1581–1591 (2003).
Neuschwander-Tetri, B. A. et al. Lancet 385, 956–965 (2015).
Loomba, R. et al. Hepatology 67, 549–559 (2018).
Pawlak, M. et al. Hepatology 60, 1593–1606 (2014).
Ratziu, V. et al. Gastroenterology 150, 1147–1159 (2016).
Friedman, S. L. et al. Hepatology 67, 1754–1767 (2018).
Armstrong, M. J. et al. Lancet 387, 679–690 (2016).
Patel, K. et al. Hepatology 68 (Suppl. 1), 438A, abstract 736 (2018).
Luo, J. et al. Sci. Transl. Med. 6, 247ra100 (2014).
Harrison, S. A. et al. Lancet 391, 1174–1185 (2018).
Romeo, S. et al. Nat. Genet. 40, 1461–1465 (2008).
Yuan, X. et al. Am. J. Hum. Genet. 83, 520–528 (2008).
Linden D. et al. Hepatology 68 (Supp. 1), 440A, abstract 740 (2018).
Kozlitina, J. et al. Nat. Genet. 46, 352–356 (2014).
Abul-Husn, N. S. et al. N. Engl. J. Med. 378, 1096–1106 (2018).
Ma, Y. et al. Hepatology https://doi.org/10.1002/hep.30350 (2018).
About, F., Abel, L. & Cobat, A. N. Engl. J. Med. 379, 1875–1876 (2018).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Garber, K. The new liver epidemic. Nat Biotechnol 37, 209–214 (2019). https://doi.org/10.1038/s41587-019-0047-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-019-0047-9